High glucose promotes the release and expression of novel vasoactive peptide, coupling factor 6, in human umbilical vein endothelial cells

Peptides

Volumn 28, Issue 3, 2007, Pages 683-690

  Li, Xiaolu ^a,c   Xing, Shanshan ^a   Zhang, Like ^b   Xing, Qichong ^c   Yan, Suhua ^c   Dai, Hongyan ^a   You, Shuling ^d   Pang, Yongzheng ^e   Tang, Chaoshu ^e  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^d Department of Pathophysiology   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Coupling factor 6; Endothelial cells; High glucose; p38 Mitogen activated protein kinase; Protein kinase C

Indexed keywords

COUPLING FACTOR 6; GLUCOSE; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE DERIVATIVE; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; OSMOLARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UMBILICAL VEIN;

BASE SEQUENCE; CELLS, CULTURED; DIABETES MELLITUS; DNA PRIMERS; ENDOTHELIAL CELLS; GENE EXPRESSION; GLUCOSE; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; OXIDATIVE PHOSPHORYLATION COUPLING FACTORS; PROTEIN KINASE C; RNA, MESSENGER;

EID: 33846833789     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.11.006     Document Type: Article

References (38)

1. Aljada A., and Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 49 (2000) 147-150
2. Awazu M., Ishikura K., Hida M., and Hoshiya M. Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. J Am Soc Nephrol 10 (1999) 738-745
3. Candido R., and Zanetti M. Current perspective. Diabetic vascular disease: from endothelial dysfunction to atherosclerosis. Ital Heart J 6 (2005) 703-720
4. Chang J.K., Scruggs P., Yang J., Ouyang M., Duetzmann A., and Dun N.J. Total synthesis of human and rat coupling factor-6 amide and pressor effects in the rat. Regul Pept 113 (2003) 63-69
5. Ding W.H., Chu S.Y., Jiang H.F., Cai D.Y., Pang Y.Z., Tang C.S., et al. Plasma mitochondrial coupling factor 6 in patients with acute myocardial infarction. Hypertens Res 27 (2004) 717-722
6. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
7. Guha M., Bai W., Nadler J.L., and Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275 (2000) 17728-17739
8. Haneda M., Kikkawa R., Sugimoto T., Koya D., Araki S., and Togawa M. Abnormalities in protein kinase C and MAP kinase cascade in mesangial cells cultured under high glucose conditions. J Diabetes Complications 9 (1995) 246-248
9. Higuti T., Tsurumi C., Kawamura Y., Tsujita H., Osaka F., Yoshihara Y., et al. Molecular cloning of cDNA for the import precursor of human coupling factor 6 of H(+)-ATP synthase in mitochondria. Biochem Biophys Res Commun 178 (1991) 793-799
10. Igarashi M., Wakasaki H., Takahara N., Ishii H., Jiang Z.Y., Yamauchi T., et al. Rhodes and glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103 (1999) 185-195
11. Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272 (1996) 728-731
12. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52 (1973) 2745-2756
13. Kramer R.M., Roberts E.F., Um S.L., Borsch-Haubold A.G., Watson S.P., Fisher M.J., et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 271 (1996) 27723-27729
14. Li XL, Xing QC, Dong B, Gao YY, Xing SS, Pangd YZ, et al. Plasma level of mitochondrial coupling factor 6 increases in patients with type 2 diabetes mellitus. Int J Cardiol 2006 Aug 7; [Epub ahead of print], in press.
15. Li L., Sawamura T., and Renier G. Glucose enhances endothelial LOX-1 expression: role for LOX-1 in glucose-induced human monocyte adhesion to endothelium. Diabetes 52 (2003) 1843-1850
16. Li R.C., Ping P., Zhang J., Wead W.B., Cao X., Gao J., et al. PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 279 (2000) H1679-H1689
17. Malmberg K., Malmberg K., Yusuf S., Gerstein H.C., Brown J., Zhao F., et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS Registry. Circulation 102 (2000) 1014-1019
18. Marquardt B., Frith D., and Stabel S. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9 (1994) 3213-3218
19. Moser T.L., Stack M.S., Asplin I., Enghild J.J., Hojrup P., Everitt L., et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 96 (1999) 2811-2816
20. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
21. Osanai T., Kamada T., Fujiwara N., Katoh T., Takahashi K., Kimura M., et al. A novel inhibitory effect on prostacyclin synthesis of coupling factor 6 extracted from the heart of spontaneously hypertensive rats. J Biol Chem 273 (1998) 31778-31783
22. Osanai T., Okada S., Sirato K., Nakano T., Saitoh M., Magota K., et al. Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress. Circulation 104 (2001) 3132-3136
23. Osanai T., Sasaki S., Kamada T., Fujiwara N., Nakano T., Tomita H., et al. Circulating coupling factor 6 in human hypertension: role of reactive oxygen species. J Hypertens 2 (2003) 2323-2328
24. Osanai T., Nakamura M., Sasaki S., Tomita H., Saitoh M., Osawa H., et al. Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Kidney Int 64 (2003) 2291-2297
25. Osanai T., Tanaka M., Kamada T., Nakano T., Takahashi K., Okada S., et al. Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor. J Clin Invest 108 (2001) 1023-1030
26. Patton J., Block S., Coombs C., and Martin M.E. Identification of functional elements in the murine Gabp alpha/ATP synthase coupling factor 6 bi-directional promoter. Gene 369 (2006) 35-44
27. Pieper G.M., and Riaz-ul-Haq. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 30 (1997) 528-532
28. Rojas S., Rojas R., Lamperti L., Casanello P., and Sobrevia L. Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium. Exp Physiol 88 (2003) 209-219
29. Sasaki S., Osanai T., Tomita H., Matsunaga T., Magota K., and Okumura K. Tumor necrosis factor alpha as an endogenous stimulator for circulating coupling factor 6. Cardiovasc Res 62 (2004) 578-586
30. Tanaka M., Osanai T., Murakami R., Sasaki S., Tomita H., Maeda N., et al. Effect of vasoconstrictor coupling factor 6 on gene expression profile in human vascular endothelial cells: enhanced release of asymmetric dimethylarginine. J Hypertens 24 (2006) 489-497
31. Tian W., Zhang Z., and Cohen D.M. MAPK signaling and the kidney. Am J Physiol Renal Physiol 279 (2000) F593-F604
32. Tomita H., Osanai T., Toki T., Sasaki S., Maeda N., Murakami R., et al. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. Cardiovasc Res 67 (2005) 134-141
33. Vanhorebeek I., Langouche L., and Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness?. Curr Opin Crit Care 11 (2005) 304-311
34. Warfel N.A., Lepper E.R., Zhang C., Figg W.D., and Dennis P.A. Importance of the stress kinase p38alpha in mediating the direct cytotoxic effects of the thalidomide analogue, CPS49, in cancer cells and endothelial cells. Clin Cancer Res 12 (2006) 3502-3509
35. Wu Q.D., Wang J.H., Fennessy F., Redmond H.P., and Bouchier-Hayes D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 277 (1999) C1229-C1238
36. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
37. Yki-Jarvinen H. Nonglycemic effects of insulin. Clin Cornerstone Suppl. 4 (2003) S6-S12
38. Zeng G., and Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98 (1996) 894-898